Kevin W. Massengill is the Executive Chairman of Meraglim Holdings Corporation, a professional, scientific, and technical investment holding company, and the CEO of Raven Predictive Analytics® a patent-pending enterprise SaaS combining AI, complexity science, and human intelligence for institutional investors and corporate leaders. He is also the Managing Director of Massengill Advisory LLC, a Florida-based business consultancy and family office managing investments in hard assets and private equity.
Massengill is currently the Non-Executive Chairman of the Board for several acquisition-focused QLA investment holding companies: Brighter Electrical, Caliburn Capital, EVI Holdings, Huntingstone Partners, Impact Holdings, NorthStar Essential Holdings, Optimized Growth Holdings, Panthera Senior Living, Prime Regency, RecordAI, United Pain Clinics, Vernal Partners, White Strix Holdings, and others in development.
A retired U.S. Army Airborne Ranger qualified officer and award-winning senior defense executive with Fortune 500 companies Raytheon Technologies (NYSE: RTX) and Leidos Holdings (NYSE: LDOS), Massengill also served as a managing director of Silver Leaf Partners, a boutique New York investment bank.
Massengill has previously served as Chairman of the Board for the Leidos (NYSE: LDOS) operating businesses in Australia, Saudi Arabia, and the United Kingdom, a member of the Overseas Schools Advisory Council for the U.S. Department of State - D.C., a Non-Executive Board Director for GrowthGate Capital, a private equity buy out firm in Dubai, and as Chairman of the Board of Trustees for the American Community School - Abu Dhabi.
Massengill holds an M.A. in Near Eastern Studies from Princeton University, a B.A. in Russian Area Studies from the University of Missouri-Columbia where he was a Distinguished Military Graduate, the recipient of the George C. Marshall Award, and a US Army Top 5% Fellowship. He has completed the International Directors Program at INSEAD Fontainebleau, the Program on Negotiation for Senior Executives at Harvard Law School, and held FINRA Series 7 and Series 63 licenses.